265 related articles for article (PubMed ID: 18971100)
1. An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation.
Murray DL; Pereira NL; Miller DV
J Heart Lung Transplant; 2008 Nov; 27(11):1257-61. PubMed ID: 18971100
[TBL] [Abstract][Full Text] [Related]
2. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
[TBL] [Abstract][Full Text] [Related]
3. A case of fulminant post-transplant lymphoproliferative disorder and septicemia.
Gouya G; Hartmann G; Faè P; Tauber M; Holzmüller H; Benzer W; Lang A; Schuster A; Drexel H; Offner FA
Clin Transplant; 2006; 20(2):261-4. PubMed ID: 16640537
[TBL] [Abstract][Full Text] [Related]
4. Late allograft failure after heart transplantation: 2 unusual cases.
Boilson BA; Miller DV; Pereira NL
J Heart Lung Transplant; 2008 Sep; 27(9):1050-4. PubMed ID: 18765202
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient.
Eisen HJ; Hicks D; Kant JA; Montone KT; Mull R; Pigott J; Tomaszewski JE
J Heart Lung Transplant; 1994; 13(2):241-5. PubMed ID: 8031806
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of allograft neutrophilic myocarditis mimicking acute myocardial infarction in a post-heart transplant patient.
Goland S; Luthringer D; Shirvani V; Trento A; Czer LS
J Heart Lung Transplant; 2009 Aug; 28(8):843-6. PubMed ID: 19632583
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disorder limited to the skin.
Samolitis NJ; Bharadwaj JS; Weis JR; Harris RM
J Cutan Pathol; 2004 Jul; 31(6):453-7. PubMed ID: 15186434
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorder with supraglottic involvement.
Rombaux P; Marque A; Hamoir M; Smets F; Sokal E
B-ENT; 2005; 1(1):53-6. PubMed ID: 15999677
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant Lymphoproliferative Disorders: A Rare Case of Primary Pericardial Involvement Epstein-Barr Virus-Correlated in Heart Transplantation.
Toscano G; Fabozzo A; Fedrigo M; Gambino A; Angelini A; Gerosa G
Transplant Proc; 2015 Sep; 47(7):2287-90. PubMed ID: 26361701
[TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.
Khalpey Z; Miller DV; Schmitto JD; Kushwaha SS
Transplant Proc; 2011 Jun; 43(5):1893-9. PubMed ID: 21693296
[TBL] [Abstract][Full Text] [Related]
13. Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: report of three cases.
Codeluppi M; Cocchi S; Guaraldi G; Di Benedetto F; Bagni A; Pecorari M; Gennari W; Pinna AD; Gerunda GE; Esposito R
Transplant Proc; 2005; 37(6):2634-5. PubMed ID: 16182770
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
15. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child.
Sebire NJ; Malone M; Ramsay AD
Pediatr Dev Pathol; 2004; 7(3):290-3. PubMed ID: 15148593
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 typing by micro-bead array assay identifies the origin of early lymphoproliferative disorder in a heart transplant recipient.
Fedrigo M; Poli F; Esposito G; Feltrin G; Toscano G; d'Agostino C; Schiavon B; Gerosa G; Amadori A; Valente M; Thiene G; Angelini A
Am J Transplant; 2013 Mar; 13(3):802-7. PubMed ID: 23331771
[TBL] [Abstract][Full Text] [Related]
18. Extensive cardiac allograft vasculitis and concurrent fat necrosis 6 years after orthotopic heart transplantation.
Cuda JD; Baldwin WM; Steenbergen C; Judge DP; Dropulic LK; Halushka MK
J Heart Lung Transplant; 2007 Nov; 26(11):1212-6. PubMed ID: 18022091
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus associated with a post-transplant lymphoproliferative disorder presenting as isolated gastrointestinal tract bleeding.
Badham K; Mirchandani A; Arumainayagam N; West DR
Endoscopy; 2007 Feb; 39 Suppl 1():E64-5. PubMed ID: 17323282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
